End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,274 INR | -1.02% | -0.30% | +30.42% |
Apr. 22 | Epigral's Consolidated Profit Climbs in Fiscal Q4; Shares Up 4% | MT |
Apr. 22 | Epigral Limited Recommends Final Dividend for the Financial Year Ended March 31, 2024 | CI |
Sales 2022 | 15.51B 186M | Sales 2023 | 21.88B 263M | Capitalization | 39.21B 471M |
---|---|---|---|---|---|
Net income 2022 | 2.53B 30.36M | Net income 2023 | 3.53B 42.43M | EV / Sales 2022 | 3.23 x |
Net Debt 2022 | 9.68B 116M | Net Debt 2023 | 8.65B 104M | EV / Sales 2023 | 2.19 x |
P/E ratio 2022 |
16
x | P/E ratio 2023 |
11.1
x | Employees | 936 |
Yield 2022 * |
-
| Yield 2023 |
0.53% | Free-Float | 28.48% |
1 day | -1.02% | ||
1 week | -0.30% | ||
Current month | -3.79% | ||
1 month | -1.61% | ||
3 months | +21.11% | ||
6 months | +39.77% | ||
Current year | +30.42% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 39 | 17-05-17 | |
Director of Finance/CFO | - | 14-05-06 | |
Chairman | 41 | 17-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | - | |
Chairman | 41 | 17-03-31 | |
Director/Board Member | 37 | 16-05-09 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 112 M€ | +5.41% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 1,274 | -1.02% | 17,702 |
24-05-16 | 1,287 | +0.29% | 25,874 |
24-05-15 | 1,284 | -1.33% | 26,408 |
24-05-14 | 1,301 | +4.10% | 45,635 |
24-05-13 | 1,250 | -2.21% | 71,742 |
End-of-day quote NSE India S.E., May 16, 2024
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+30.42% | 636M | |
+5.41% | 106B | |
-3.11% | 64.74B | |
+73.33% | 49.34B | |
+17.24% | 39.15B | |
+6.13% | 32.86B | |
+12.77% | 20.29B | |
+15.03% | 17.21B | |
+19.06% | 15.28B | |
+6.28% | 14.58B |
- Stock Market
- Equities
- EPIGRAL Stock